Our study demonstrated that both the AA homozygotes in CCL5 rs2107538 and the GA heterozygotes in CXCR2 rs1126580 had significantly been associated with an increased risk of endometrial cancer. This evidence concerns the gene CXCR2 and endometrial cancer.